Sugammadex improves diaphragmatic excursion and reduces pulmonary complications in morbidly obese patients
Sugammadex Helps Obese Patients Breathe Easier
A randomized double-blind controlled trial in 104 morbidly obese patients compared sugammadex (2 mg/kg) with neostigmine+atropine. Sugammade…
This new research shows that a specific reversal drug helps morbidly obese patients breathe better and avoid lung issues after surgery.
Neostigmine infusion in septic shock linked to lower TNF-alpha and 28-day mortality in single-center RCT
Neostigmine infusion linked to lower inflammation and mortality in septic shock trial
A single-center randomized controlled trial in adult ICU patients with septic shock compared a 5-day neostigmine infusion (0.2 mg/hr) to pla…
Septic shock patients receiving neostigmine showed lower inflammation, better organ scores, and fewer deaths compared to those on placebo in…